Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saroglitazar Magnesium in Primary Biliary Cholangitis (EPICS)
NCT03112681Phase 2Completed
- Sponsor
- Zydus Therapeutics
- Start
- Aug 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saroglitazar magnesium in primary biliary cholangitis (PBC), sponsored by Zydus Therapeutics. Started Aug 2017; status: completed.
02
Drugs
saroglitazar magnesium
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT03112681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112681.